June 25-28, 2024, 2024 MiSi Conference·The China Medical and Health Industry Symbiosis Conference was grandly held at the Taihu Dragon Dream Diamond Hotel in Nanhu Lake, China.

At the conference, relying on the MiNet network's database for three major terminals and six markets that has been developed and operated exclusively in China for many years, the "2023 Chinese Top 100 Pharmaceutical Industries List" was officially released for pharmaceutical industrial enterprises, based on two most important dimensions—“innovation drive” and “professional promotion ability”.

During the selection process of the “2023 Top 100 Chinese Pharmaceutical Industries List”, professional research institutions, industry experts and scholars, entrepreneurs, and peers in the industry have shown great attention and active participation, and have given high praise.

      With its strong R&D and production capabilities, as well as excellent marketing skills, Hisicor Pharmaceutical Group was successfully selected into the sub-list “2023 Chinese Pharmaceutical Enterprises TOP100 Ranking” of the “2023 China Pharmaceutical Industry Top 100 List”.

In 2024, Hisicor Pharmaceutical Group remains committed to the “resilience” of unremitting effort, breaking through obstacles, and creating new opportunities. By innovating and iterating to cope with uncertainty, it enhances its resilience, adheres to high-quality development, and seizes the opportunities offered by the economy and society in the new era.